MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 54 filers reported holding MEDGENICS INC in Q2 2015. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,149,000 | +18.1% | 744,794 | +17.7% | 0.00% | 0.0% |
| Q2 2016 | $3,512,000 | +41.4% | 632,813 | +12.1% | 0.00% | 0.0% |
| Q1 2016 | $2,483,000 | -30.8% | 564,359 | -5.4% | 0.00% | 0.0% |
| Q4 2015 | $3,590,000 | +4.7% | 596,347 | +36.0% | 0.00% | 0.0% |
| Q3 2015 | $3,430,000 | +26.1% | 438,580 | -1.2% | 0.00% | 0.0% |
| Q2 2015 | $2,720,000 | +688.4% | 443,740 | +935.8% | 0.00% | – |
| Q1 2015 | $345,000 | +48.7% | 42,840 | -6.4% | 0.00% | – |
| Q4 2014 | $232,000 | +5.5% | 45,752 | +7.7% | 0.00% | – |
| Q3 2014 | $220,000 | -37.9% | 42,476 | -6.8% | 0.00% | – |
| Q2 2014 | $354,000 | +14.6% | 45,570 | +2.9% | 0.00% | – |
| Q1 2014 | $309,000 | +47.8% | 44,266 | +27.2% | 0.00% | – |
| Q4 2013 | $209,000 | -3.2% | 34,811 | +26.0% | 0.00% | – |
| Q3 2013 | $216,000 | +122.7% | 27,633 | +8.6% | 0.00% | – |
| Q2 2013 | $97,000 | – | 25,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,058,400 | $8,277,000 | 4.07% |
| Belmont Global Advisors, Inc. | 155,000 | $1,212,000 | 2.06% |
| Broadfin Capital, LLC | 1,545,306 | $12,084,000 | 0.67% |
| CARL DOMINO INC | 34,134 | $267,000 | 0.21% |
| QVT Financial LP | 267,608 | $2,093,000 | 0.07% |
| WHITE PINE CAPITAL LLC | 20,000 | $156,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119,000 | $931,000 | 0.02% |
| HYMAN CHARLES D | 13,000 | $102,000 | 0.02% |
| Kavar Capital Partners, LLC | 1,500 | $11,000 | 0.01% |
| Brick & Kyle, Associates | 1,000 | $8,000 | 0.01% |